全文获取类型
收费全文 | 3777篇 |
免费 | 208篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 84篇 |
妇产科学 | 37篇 |
基础医学 | 574篇 |
口腔科学 | 61篇 |
临床医学 | 254篇 |
内科学 | 1019篇 |
皮肤病学 | 43篇 |
神经病学 | 254篇 |
特种医学 | 125篇 |
外科学 | 743篇 |
综合类 | 8篇 |
预防医学 | 85篇 |
眼科学 | 34篇 |
药学 | 196篇 |
中国医学 | 2篇 |
肿瘤学 | 440篇 |
出版年
2023年 | 21篇 |
2022年 | 35篇 |
2021年 | 68篇 |
2020年 | 37篇 |
2019年 | 55篇 |
2018年 | 72篇 |
2017年 | 60篇 |
2016年 | 89篇 |
2015年 | 78篇 |
2014年 | 108篇 |
2013年 | 170篇 |
2012年 | 222篇 |
2011年 | 243篇 |
2010年 | 136篇 |
2009年 | 108篇 |
2008年 | 215篇 |
2007年 | 217篇 |
2006年 | 248篇 |
2005年 | 237篇 |
2004年 | 238篇 |
2003年 | 204篇 |
2002年 | 215篇 |
2001年 | 83篇 |
2000年 | 88篇 |
1999年 | 72篇 |
1998年 | 78篇 |
1997年 | 65篇 |
1996年 | 39篇 |
1995年 | 41篇 |
1994年 | 34篇 |
1993年 | 39篇 |
1992年 | 37篇 |
1991年 | 41篇 |
1990年 | 36篇 |
1989年 | 40篇 |
1988年 | 29篇 |
1987年 | 27篇 |
1986年 | 30篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 17篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1975年 | 9篇 |
1974年 | 8篇 |
1971年 | 7篇 |
1968年 | 5篇 |
排序方式: 共有4018条查询结果,搜索用时 15 毫秒
51.
52.
S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial. 总被引:3,自引:0,他引:3
Yukito Ichinose Kozo Yoshimori Hiroshi Sakai Yushi Nakai Takahiko Sugiura Masaaki Kawahara Hisanobu Niitani 《Clinical cancer research》2004,10(23):7860-7864
PURPOSE: To evaluate the efficacy and toxicity of a novel combination chemotherapeutic regimen including cisplatin with an oral anticancer agent, S-1 that consisted of tegafur, 5-chloro-2, 4-dihydroxypyridine, and potassium oxonate, for non-small-cell lung cancer (NSCLC) patients. EXPERIMENTAL DESIGN: In this phase II trial, patients with locally advanced and metastatic NSCLC were treated with the oral administration of S-1 at 40 mg/m(2) twice a day for 21 consecutive days while cisplatin (60 mg/m(2)) was administered intravenously on day 8. This schedule was repeated every 5 weeks. RESULTS: Of 56 patients enrolled in the study, 55 patients were eligible and analyzed. The median number of cycles administered was 3 (range, 1-12 cycles). Among these 55 patients, one complete response and 25 partial responses were observed with an overall response rate of 47% (95% confidence interval, 34-61%). The median survival time was 11 months and the 1-year survival rate was 45%. Hematologic toxicities of grades 3 and 4 included neutropenia (29%) and anemia (22%). No grade 4 nonhematologic toxicity was observed. Grade 3 toxicity included anorexia (13%), vomiting (7%), or diarrhea (7%). CONCLUSIONS: S-1 plus cisplatin combination chemotherapy showed a promising effectiveness with acceptable toxicity rates in patients with advanced NSCLC. These results warrant further investigations of this regimen including a randomized controlled trial for its use as a first line treatment for NSCLC. 相似文献
53.
54.
Masuda H Ozawa M Kurita S Saito Y Ichinose Y 《Hinyokika kiyo. Acta urologica Japonica》2000,46(12):923-925
We investigated the clinical statistics of the operations and inpatients since the establishment of the department in June 1994 up to May 1999. The total number of inpatients was 1,269 (1,047 males and 222 females), and a total of 1,098 operations were performed. Extracorporeal shock wave lithotriopy (ESWL) was also introduced in 1997, and in addition, it seemed that the number of operations and inpatients would be increasing in future. 相似文献
55.
Kazumasa Miki Masao Ichinose Norio Kawamura Masashi Matsushima Haron Bin Ahmad Masayoshi Kimura Junjiro Sano Takao Tashiro Nobuyuki Kakei Hiroshi Oka Chie Furihata Kenji Takahashi 《Cancer science》1989,80(2):111-114
Serum pepsinogen levels were measured in 137 stomach cancer patients and compared with those of 288 normal cancer-free subjects. The serum pepsinogen levels of stomach cancer patients, especially pepsinogen I and the pepsinogen I/pepsinogen II ratio were significantly lower than those of normal controls and correlated well with the extent of chronic gastritis associated with the cancerous stomach. These results were in good accordance with the results of previous studies indicating that the cancer derived from the stomach where chronic gastritis/intestinal metaplasia is extensive. The high sensitivity and specificity of this non-invasive serum test to detect chronic gastritis suggested the possibility of its application to the mass screening of stomach cancer. 相似文献
56.
CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine
下载免费PDF全文
![点击此处可从《Cancer science》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Nobuhiko Ohnishi Katsuyoshi Takata Tomoko Miyata‐Takata Yasuharu Sato Akira Tari Yuka Gion Mai Noujima‐Harada Kohei Taniguchi Tetsuya Tabata Keina Nagakita Shizuma Omote Hiroyuki Takahata Masaya Iwamuro Hiroyuki Okada Yoshinobu Maeda Hiroyuki Yanai Tadashi Yoshino 《Cancer science》2016,107(11):1687-1695
Follicular lymphoma (FL) shows co‐expression of B‐cell lymphoma 2 (BCL2) and CD10, whereas downexpression of CD10 is occasionally experienced in gastrointestinal (GI) FL with unknown significance. Gastrointestinal FL is a rare variant of FL, and its similarity with mucosa‐associated lymphoid tissue lymphoma was reported. We investigated the clinicopathological and genetic features of CD10 downexpressed (CD10down) GI‐FL. The diagnosis of CD10down FL was carried out with a combination of pathological and molecular analyses. The incidence of CD10down GI‐FL was shown in 35/172 (20.3%) cases, which was more frequent than nodal FL (3.5%, P < 0.001). The difference was additionally significant between GI‐FL and nodal FL when the analysis was confined to primary GI‐FL (55.2% vs 3.5%, P < 0.001). Compared to CD10+ GI‐FL, CD10down GI‐FL significantly involved the stomach or large intestine (P = 0.015), and additionally showed the downexpression of BCL6 (P < 0.001). The follicular dendritic cell meshwork often showed a duodenal pattern in the CD10down group (P = 0.12). Furthermore, a lymphoepithelial lesion was observed in 5/12 (40%) gastric FL cases, which indicated caution in the differentiation of mucosa‐associated lymphoid tissue lymphoma. Molecular analyses were undertaken in seven cases of CD10down GI‐FL, and an identical clone was found between CD10down follicles and CD10+BCL2+ neoplastic follicles. In the diagnosis of cases with CD10down BCL2+ follicles, careful examination with molecular studies should be carried out. 相似文献
57.
Ichinose K Tomiyama N Nakashima M Ohya Y Ichikawa M Ouchi T Kanematsu T 《Anti-cancer drugs》2000,11(1):33-38
The in vivo antitumor activity and toxicity of a newly synthesized polymeric prodrug of cisplatin was investigated and also compared with plain cisplatin. The prodrug included a dicarboxymethyl-dextran conjugate of cisplatin (DCM-Dex/CDDP). DCM-Dex/CDDP was i.v. injected in mice bearing s.c. Colon 26 mouse colon cancer cells. The tissue distribution of platinum was thereafter determined by flameless atomic absorption spectrophotometry. The platinic concentration of the organs showed a high rate of retention at 24 h after injection in the DCM-Dex/CDDP-treated mice. No biochemical or hematologically adverse effects were observed. In addition, DCM-Dex/CDDP showed a significantly higher antitumor activity than cisplatin alone. These results indicate that DCM-Dex/CDDP may therefore be a potentially effective cancer chemotherapy. 相似文献
58.
We analyzed clinical data from 195 patients (141 boys) with myocardial infarction complicating Kawasaki disease, collected from 74 major hospitals in Japan. The myocardial infarction usually occurred within the first year of illness, but 27.2% of the patients had myocardial infarction more than 1 year later. In 63% of the patients it occurred during sleep or at rest. The main symptoms of acute myocardial infarction were shock, unrest, vomiting, abdominal pain, and chest pain; chest pain was much more frequently recognized in the survivors and in older patients. The myocardial infarctions were asymptomatic in 37% of the patients. Twenty-two percent of the patients died during the first attack. Sixteen percent of the survivors of a first attack had a second attack. Forty-three percent of all survivors of the first or subsequent attack are doing well; however, others have some type of cardiac dysfunction, such as mitral regurgitation, decreased ejection fraction of the left ventricle, or left ventricular aneurysm. Coronary angiographic studies indicate that in most of the fatal cases there was obstruction either in the main left coronary artery or in both the main right coronary artery and the anterior descending artery. In survivors, one-vessel obstruction was frequently recognized, particularly in the right coronary artery. 相似文献
59.
60.
Naofumi Ikeda Toshihide Hayashi Shikou Gen Nobuhiko Joki Kazuhiko Aramaki 《Renal failure》2022,44(1):1098
PurposeTo determine the location of coronary atherosclerosis distribution observed in patients with chronic kidney disease (CKD).MethodsA cross-sectional study was conducted using the database of cardiovascular medicine data from Saitama Sekishinkai Hospital to clarify the association between renal function and angiographic characteristics of coronary atherosclerosis. In total, 3268 patients who underwent percutaneous coronary intervention were included. Propensity score matching revised the total to 1772. The association of renal function with the location and/or distribution of coronary atherosclerosis lesions was then examined.ResultsOverall, coronary lesion was observed in the left anterior descending coronary artery (LAD) in 56% patients, whereas 28% and 22% were in the right coronary artery (RCA) and left circumflex coronary artery (LCX), respectively. LAD was most affected and observed in 57% patients with stage 1 CKD. RCA was second-most affected, at 26% CKD stage 1, but it increased to 31%, 38%, and 59% in CKD 3, 4, and 5, respectively. In CKD 5 patients, the RCA was the most affected artery (59%), with 41% LAD lesions. Logistic regression analysis after propensity score matching showed that the odds ratios for an RCA lesion was 3.658 in CKD 5 (p = .025) compared with CKD 1 after adjusting for traditional risk factors.ConclusionThe prevalence of RCA lesions, but not LAD or LCX lesions, increased with increasing CKD stage. The pathophysiology of coronary atherosclerosis may differ by lesion location. Deterioration of renal function may affect progression of atherosclerosis more in the RCA than in the LAD or LCX. 相似文献